Panelists discuss how understanding the epidemiology, clinical presentation, and metastatic patterns of epithelioid sarcoma (ES) can support earlier recognition, accurate diagnosis, and more effective multidisciplinary management of this rare and aggressive soft tissue tumor.
Summary for Physicians: Epidemiology and Landscape of Epithelioid Sarcoma (ES)
Epithelioid sarcoma (ES) is a rare, aggressive soft tissue sarcoma that primarily affects adolescents and young adults, with a slight male predominance. It most often arises in the distal extremities but can also occur in proximal areas, which may complicate diagnosis. ES is known for its high rates of local recurrence and potential for both regional lymph node involvement and distant metastasis, particularly to the lungs. Due to its rarity and variable presentation, ES poses significant diagnostic and therapeutic challenges, emphasizing the importance of early recognition and multidisciplinary care.
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Recap: Recent Advances in the Treatment of Metastatic Castration-Sensitive Prostate Cancer
September 18th 2022Expert oncologists review key studies in the metastatic castration-resistant prostate cancer treatment landscape and discuss how evidence can be applied to clinical practice to improve patient outcomes.
Recap: Updates in Treatment of HER2-Positive Breast Cancer and Brain Metastases
July 16th 2022Sara A. Hurvitz, MD; Stefania Maraka, MD; and Ruta Rao, MD, discuss the evolving landscape of metastatic HER2+ breast cancer, highlighting recent clinical trials and the management of patients with brain metastases.
Recap: Emory Experts Review Treatment Strategies for Transplant-Ineligible Multiple Myeloma
June 20th 2022A panel of experts from Emory University review several key data updates in multiple myeloma from recent meetings and discuss how the data can be applied to clinical practice to improve patient outcomes.